首页 | 本学科首页   官方微博 | 高级检索  
检索        

PD-1受体在HBV—ACLF患者外周血CD8^+T细胞上的表达研究
引用本文:刘晓燕,石峰,赵鸿,王慧芬.PD-1受体在HBV—ACLF患者外周血CD8^+T细胞上的表达研究[J].中华实验和临床病毒学杂志,2010,24(2):125-127.
作者姓名:刘晓燕  石峰  赵鸿  王慧芬
作者单位:1. 解放军第三○二医院肝衰竭治疗研究中心,北京,100039
2. 解放军第三○二医院传染病研究所,北京,100039
基金项目:艾滋病和病毒性肝炎等重大传染病防治科技重大专项,军队"十一五"中医药研发推广专项重大临床攻关项目 
摘    要:目的探讨乙型肝炎病毒所致慢加急性肝衰竭(HBV—ACLF)患者外周血中CD8^+T细胞上PD-1(Programmed death-1)的表达以及对CD8^+T细胞的影响。方法收集60例HBV—ACLF患者外周血;应用流式细胞仪检测外周血中CD8^+淋巴细胞上的PD-1、CD95、穿孔素、颗粒酶A、颗粒酶B、CD107a的表达以及CD14细胞上PD—L1的表达;根据不同病情分期和不同预后比较各分子的表达差异;设15名肝硬化患者及15名健康人为对照组。结果(1)HBV-ACLF患者CD8^+T细胞上PD-1较肝硬化组和健康组表达上调(P〈0.05);好转组PD-1表达率低于无效组(P〈0.05);早、中、晚三期PD-1表达率呈上升趋势(P〈0.05);(2)PD—L1在好转组及病情早期表达相对最低;(3)PD-1与CD95在死亡组表达明显升高;穿孔素、颗粒酶及CD107a在死亡组表达升高,但PD-1在这三类细胞上表达率非常低。结论PD-1在HBV.ACLF患者外周血CD8^+T细胞上表达上调,且与病情严重程度呈正比。其上调表达可能促进总CD8^+T细胞的凋亡,但对于具有杀伤活性的CD8^+T细胞抑制作用相对较弱。

关 键 词:肝功能衰竭  程序性死亡分子  CD8阳性T淋巴细胞

Research of PD-1 expression in CD8~+ T cell of Peripheral blood with HBV-associated acute-onchronic liver failure
LIU Xiao-yan,SHI Feng,ZHAO Hong,WANG Hui-fen.Research of PD-1 expression in CD8~+ T cell of Peripheral blood with HBV-associated acute-onchronic liver failure[J].Chinese Journal of Experimental and Clinical Virology,2010,24(2):125-127.
Authors:LIU Xiao-yan  SHI Feng  ZHAO Hong  WANG Hui-fen
Institution:. (Liver Failure Treatment and Research Center, 302 Hospital of PLA, Beijing 100039, China)
Abstract:Objective To analyze PD-1 expression in CD8~+T cell of Peripheral blood with HBV-associated acute-on-chronic liver failure and effect on CD8~+T cell.Methods We selected 60 patients with HBV-ACLF and collected their peripheral blood.We analyzed the expressions of PD-1,CD95,perforin,granzyme A,granzyme B,CD107a on CD8~+T lymphocytes and the expression of PD-L1 on monocytes in peripheral blood by using flow cytometry.15 liver cirrhosis patients(LC) and 15 healthy individuals(HC) are control groups.Result PD-1 expression was (1)The PD-1 expression in HBV-ACLF patients was significantly elevated compared with those in HC and lower in improved group than that in invalid group and death group (P<0.05) and increased from prophase,metaphase to advanced stage (P<0.05).Moreover.(2)PD-L1 expression on monocytes was positively correlated with disease progression.(P<0.05).(3)Both PD-1 and CD95 expressions were higher in dead group than those in improved and non-improved groups.Perforin,granzymes and CD107a expressions on CD8~+ T cells significantly increased in dead group compared with those in improved and non-improved groups (P<0.05).However,PD-1 expressions on these cells were lower,compared with normal persons.Conclusions The expression of PD-1 and PD-L1 in HBV-ACLF patients was positively correlated with disease progression.The elevated PD-1 expression promoted apoptosis of CD8~+T ceils.For HBV-ACLF patients,the PD-1 expression on effector CD8~+T cells was lower than those in other CD8~+T cells,which maybe accounted for the failure to controlling immune injury in liver.
Keywords:Liver failure  PD-1  CD8-Positive T-lymphocytes
本文献已被 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号